Asset Manager

Updated:

Keleops

Alain Andrey runs Keleops, a Zug-based hedge-fund seeder that has backed specialist manager Rhenman since 2003 in a two-decade partnership.

Keleops logo

Keleops

Keleops AG was founded in 1996 and operates from Zug, Switzerland, under the direction of Senior Portfolio Manager Alain Andrey. The firm specializes in seeding and accelerating specialist hedge fund strategies, with a model built around identifying a small number of managers and committing for the long term. Its most publicly documented relationship is with Rhenman & Partners Asset Management, a Stockholm-based healthcare-focused equity fund manager, where Keleops acted as the founding seed investor in 2003. Keleops deploys capital in a structured hedge-fund seeding model, entering at the general-partner level in exchange for a share of management-company economics and fee streams. The primary disclosed strategy is a long/short healthcare equity fund via Rhenman — an intensely specialized mandate spanning global pharmaceutical, biotechnology, and medical-device equities. Unlike multi-manager platforms that rotate exposures, Keleops maintains a concentrated approach: the Rhenman partnership has run for over twenty years without rotation, suggesting a permanent-capital or semi-permanent orientation. The firm’s geographic focus is European by domicile but global by mandate. The firm’s lean structure reflects its concentrated partnership model. Senior Advisor Pierre Bonamy joined the firm’s orbit in recent years, bringing institutional structuring expertise (per FundMap, 2024). Keleops has maintained an exceptionally low public profile, with no disclosed additional offices outside Zug and no marketing presence on major professional networks — a posture consistent with a firm that sources opportunities via private networks rather than competitive RFPs. Keleops’ structural differentiator is not scale but duration. Most seeding platforms operate on five-to-seven-year harvest cycles. Keleops’ two-decade anchor partnership with Rhenman implies a permanent-capital partnership model where the seed investor functions as an enduring strategic partner rather than a staged financial backer. That architecture makes it one of the longest continually active single-manager seed relationships in European alternatives.

General information

Firm type

Asset Manager

Year founded

1996

AUM

Undisclosed

Location

Region

Europe

Country

Switzerland

City

Zug

Corporate office

Zug, Switzerland

Principals

Alain S. Andrey

Senior Portfolio Manager

Pierre Bonamy

Senior Advisor

Sector focus

Hedge FundsFinancial Services

Frequently asked questions

What is Keleops' seeding model?

Keleops provides early-stage capital to specialist hedge fund managers in exchange for a share of management-company economics and fee revenue. Rather than acting as a passive limited partner, the firm takes a general-partner interest, aligning its returns with the long-term growth of the underlying management company. The model is concentrated and partnership-driven, not a diversified incubator portfolio.

Which managers has Keleops seeded?

Keleops' most documented seed relationship is with Rhenman & Partners Asset Management, a Stockholm-based healthcare-focused equity manager. The firm provided founding capital in 2003 and has maintained the partnership for over twenty years. The longevity suggests an open-ended or permanent-capital framework rather than a standard seed-to-harvest structure.

Who makes investment decisions at Keleops?

Senior Portfolio Manager Alain Andrey leads investment decisions and strategic direction at Keleops. He is the firm's principal executive and has stewarded the Rhenman partnership since its inception. Senior Advisor Pierre Bonamy, an experienced structuring professional, supports the firm on institutional matters (per FundMap, 2024).

Does Keleops invest in strategies beyond healthcare equities?

Public record confirms only the Rhenman & Partners relationship, which runs a long/short global healthcare equity strategy across pharmaceuticals, biotechnology, and medical devices. Keleops has not publicly disclosed seeding additional managers or expanding into other strategy verticals, making its public footprint appear tightly focused on this single, long-duration partnership.

Why is Keleops based in Zug, Switzerland?

Zug is a well-established Swiss canton for alternative-asset managers, offering a stable regulatory environment, favorable corporate tax treatment, and proximity to European institutional capital. For a low-profile seeding firm like Keleops, Zug provides operational and tax efficiency suited to a permanent-capital partnership model that does not rely on marketing or frequent capital raises.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Zug Asset Manager profiles